Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Han Han

Showing results (741-750 of 756) with videos related to

Pageof 76
Sort By:
Cancer Research|August 12, 2021
Targeting <i>HER2</i> Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor MobocertinibHan Han, Shuai Li, Ting Chen, et al.
Current Biology : CB|April 4, 2017
The Evolution of Fangs, Venom, and Mimicry Systems in Blenny FishesNicholas R Casewell, Jeroen C Visser, Kate Baumann, et al.
The British Journal of Ophthalmology|April 15, 2026
Real-world effect of vitrectomy combined with intravitreal conbercept for treatment of vitreous haemorrhage in proliferative diabetic retinopathy (QILIN I): a prospective cohort studyYuanyuan Liu, Jinglin Huang, Mingxin Ao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2017
Acquired <i>MET</i> Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung CancerAnna Li, Jin-Ji Yang, Xu-Chao Zhang, et al.
Translational Lung Cancer Research|May 19, 2020
Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohortYong Song, Chengping Hu, Zhanhong Xie, et al.
Nature Communications|September 10, 2024
Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stagesYue Zhao, Jian Gao, Jun Wang, et al.
Nature Communications|July 30, 2025
Author Correction: HC-Pro inhibits HEN1 methyltransferase activity, leading to autophagic degradation of AGO1Zhao-Jun Pan, Wei-Lun Wei, Phuong-Anh Tran, et al.
Nature Communications|March 14, 2025
HC-Pro inhibits HEN1 methyltransferase activity, leading to autophagic degradation of AGO1Zhao-Jun Pan, Wei-Lun Wei, Phuong-Anh Tran, et al.
Cancer Immunology Research|August 31, 2021
Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor ImmunogenicityHai Hu, Alireza Khodadadi-Jamayran, Igor Dolgalev, et al.
Cancer Cell|December 16, 2022
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibitionYuanwang Pan, Han Han, Hai Hu, et al.
Pageof 76

Showing results (741-750 of 756) with videos related to

Sort By:
Pageof 76
Cancer Research|August 12, 2021
Targeting <i>HER2</i> Exon 20 Insertion-Mutant Lung Adenocarcinoma with a Novel Tyrosine Kinase Inhibitor MobocertinibHan Han, Shuai Li, Ting Chen, et al.
Current Biology : CB|April 4, 2017
The Evolution of Fangs, Venom, and Mimicry Systems in Blenny FishesNicholas R Casewell, Jeroen C Visser, Kate Baumann, et al.
The British Journal of Ophthalmology|April 15, 2026
Real-world effect of vitrectomy combined with intravitreal conbercept for treatment of vitreous haemorrhage in proliferative diabetic retinopathy (QILIN I): a prospective cohort studyYuanyuan Liu, Jinglin Huang, Mingxin Ao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 12, 2017
Acquired <i>MET</i> Y1248H and D1246N Mutations Mediate Resistance to MET Inhibitors in Non-Small Cell Lung CancerAnna Li, Jin-Ji Yang, Xu-Chao Zhang, et al.
Translational Lung Cancer Research|May 19, 2020
Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohortYong Song, Chengping Hu, Zhanhong Xie, et al.
Nature Communications|September 10, 2024
Genomic and immune heterogeneity of multiple synchronous lung adenocarcinoma at different developmental stagesYue Zhao, Jian Gao, Jun Wang, et al.
Nature Communications|July 30, 2025
Author Correction: HC-Pro inhibits HEN1 methyltransferase activity, leading to autophagic degradation of AGO1Zhao-Jun Pan, Wei-Lun Wei, Phuong-Anh Tran, et al.
Nature Communications|March 14, 2025
HC-Pro inhibits HEN1 methyltransferase activity, leading to autophagic degradation of AGO1Zhao-Jun Pan, Wei-Lun Wei, Phuong-Anh Tran, et al.
Cancer Immunology Research|August 31, 2021
Targeting the Atf7ip-Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor ImmunogenicityHai Hu, Alireza Khodadadi-Jamayran, Igor Dolgalev, et al.
Cancer Cell|December 16, 2022
KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibitionYuanwang Pan, Han Han, Hai Hu, et al.
Pageof 76